ReShape Lifesciences Inc.

RSLS | NASDAQ | 5 Followers
$2.55 -0.39% -$0.01
Follow
Loading...

Profile

ReShape Lifesciences Inc. (RSLS) is a biomedical company based in the United States that focuses on the development and commercialization of innovative medical devices for the treatment of obesity and metabolic disorders. Their portfolio includes a wide range of products and services, including implantable devices and surgical procedures, that help patients achieve and maintain a healthier lifestyle. The company is known for its technological innovations and research in the field of obesity treatment. Shares of ReShape Lifesciences Inc. (RSLS) could be attractive to investors seeking opportunities in the biomedical sector with an emphasis on innovation and improving patient health.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade